Last reviewed · How we verify
Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors
Approved treatments
- Busilvex · medac GmbH
- Busulfex · Waylis
Busulfex works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death. - busulfex · Dana-Farber Cancer Institute
- Busulphan · University of Birmingham
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors patent landscape — cliff calendar, originator estates, attackable patents
- Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors treatment landscape brief
- Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors treatment updates RSS
Frequently asked questions about Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors
What drugs treat Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors?
Tracked treatments include Busilvex, Busulfex, busulfex, Busulphan.
What is the treatment for Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors?
Standard treatment for Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors includes Busilvex, Busulfex, busulfex, Busulphan. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors patent cliff · Autologous hematopoietic stem-cell transplantation for Ewing's sarcoma family of tumors CI report
- Treatment: Busilvex · medac GmbH
- Treatment: Busulfex · Waylis
- Treatment: busulfex · Dana-Farber Cancer Institute
- Treatment: Busulphan · University of Birmingham
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing